MIRM

68.11

0.58% 0.39

Dopo l'orario di chiusura: 68.11

Mirum Pharmaceuticals Inc (MIRM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché MIRM Giù? Forum Previsione

Precedente Chiudi:

$67.72

Aprire:

$67.08

Volume 24 ore:

690.45K

Relative Volume:

0.90

Capitalizzazione di mercato:

$3.42B

Reddito:

$379.25M

Utile/perdita netta:

$-77.34M

Rapporto P/E:

-42.25

EPS:

-1.6122

Flusso di cassa netto:

$-27.87M

1 W Prestazione:

-6.25%

1M Prestazione:

-7.63%

6M Prestazione:

+65.24%

1 anno Prestazione:

+65.80%

Intervallo 1D:

$66.79

$69.26

Intervallo di 1 settimana:

$66.79

$74.00

Portata 52W:

$36.88

$78.54

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Nome

Mirum Pharmaceuticals Inc

Settore

Healthcare (1134)

Industria

Biotechnology (636)

Telefono

650-667-4085

Indirizzo

989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY

Dipendente

349

Cinguettio

@mirumpharma

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

MIRM's Discussions on Twitter

Confronta MIRM con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MIRM Mirum Pharmaceuticals Inc	68.11	3.48B	379.25M	-77.34M	-27.87M	-1.6122
VRTX Vertex Pharmaceuticals Inc	409.47	105.61B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	657.53	67.99B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	442.70	58.19B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	854.65	52.40B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.70	39.60B	447.02M	-1.18B	-906.14M	-6.1812

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-24	Iniziato	TD Cowen	Buy
2025-08-11	Ripresa	Stifel	Buy
2025-05-19	Ripresa	H.C. Wainwright	Buy
2024-04-17	Iniziato	Stifel	Buy
2023-12-18	Reiterato	H.C. Wainwright	Buy
2023-11-20	Ripresa	JP Morgan	Overweight
2023-11-13	Iniziato	Morgan Stanley	Overweight
2023-10-24	Iniziato	Cantor Fitzgerald	Overweight
2023-10-17	Ripresa	Evercore ISI	Outperform
2023-09-20	Iniziato	JMP Securities	Mkt Outperform
2022-09-01	Iniziato	Citigroup	Buy
2021-09-20	Iniziato	JP Morgan	Overweight
2020-08-07	Aggiornamento	Raymond James	Outperform → Strong Buy
2020-08-03	Iniziato	H.C. Wainwright	Buy
2020-07-31	Iniziato	Piper Sandler	Overweight
2020-06-25	Iniziato	Robert W. Baird	Outperform
2019-08-12	Iniziato	Citigroup	Buy
2019-08-12	Iniziato	Evercore ISI	Outperform
2019-08-12	Iniziato	Guggenheim	Buy
2019-08-12	Iniziato	ROTH Capital	Buy
2019-08-12	Iniziato	Raymond James	Outperform

Mostra tutto

Mirum Pharmaceuticals Inc Borsa (MIRM) Ultime notizie

Nov 07, 2025

Responsive Playbooks and the MIRM Inflection - news.stocktradersdaily.com

Nov 07, 2025

Mirum to present new data on liver disease therapies at AASLD meeting - Investing.com Australia

Nov 07, 2025

Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD's The Liver Meeting - Investing News Network

Nov 07, 2025

Mirum to present new data on liver disease therapies at AASLD meeting By Investing.com - Investing.com South Africa

Nov 07, 2025

Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD’s The Liver Meeting® - Business Wire

Nov 07, 2025

Is Mirum Pharmaceuticals Inc. stock overvalued by current metrics2025 Short Interest & Verified Technical Signals - newser.com

Nov 07, 2025

Nov 06, 2025

Mirum Pharmaceuticals engages at NASPGHAN 2025 Annual Meeting - Traders Union

Nov 06, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 06, 2025

Published on: 2025-11-06 04:51:32 - newser.com

Nov 06, 2025

Why Mirum Pharmaceuticals Inc. stock is rated strong buy2025 Technical Overview & Consistent Profit Focused Trading Strategies - fcp.pa.gov.br

Nov 06, 2025

Is Mirum Pharmaceuticals Inc. (08D) stock worth buying before Fed action2025 Momentum Check & Weekly Breakout Watchlists - newser.com

Nov 06, 2025

Will Mirum Pharmaceuticals Inc. stock outperform tech sector in 2025Market Sentiment Summary & Risk Controlled Stock Alerts - fcp.pa.gov.br

Nov 06, 2025

Is Mirum Pharmaceuticals Inc. stock supported by strong cash flowsJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com

Nov 06, 2025

Nov 05, 2025

Mirum Pharmaceuticals (MIRM): Discounted Valuation Reinforces Bullish Narrative on Profit Breakthrough Potential - Yahoo Finance

Nov 05, 2025

Citizens Maintains Mirum Pharmaceuticals (MIRM) Market Outperform Recommendation - Nasdaq

Nov 05, 2025

MIRM's Q3 Earnings & Revenues Beat Estimates, 2025 View Tightened - sharewise.com

Nov 05, 2025

Will Mirum Pharmaceuticals Inc. stock gain from government policies2025 Institutional Moves & Community Consensus Stock Picks - fcp.pa.gov.br

Nov 05, 2025

Mirum Pharmaceuticals (MIRM) Projected to Post Earnings on Tuesday - MarketBeat

Nov 05, 2025

Will breakout in Mirum Pharmaceuticals Inc. lead to full recovery2025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com

Nov 05, 2025

What Analysts Are Saying About Mirum Pharmaceuticals Stock - Benzinga

Nov 05, 2025

Mirum Pharmaceuticals stock price target raised to $95 by Citizens - Investing.com Canada

Nov 05, 2025

Will Mirum Pharmaceuticals Inc. (08D) stock keep high P E multiplesJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - newser.com

Nov 05, 2025

Why Mirum Pharmaceuticals Inc. stock remains undervaluedTrend Reversal & Reliable Entry Point Trade Alerts - newser.com

Nov 05, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Nov 05, 2025